1-4 of 4
B Quesnel
Close
Sort by
Journal Articles

Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).

F. Merabet, N. Boissel, O. Reman, Jean-Henri Bourhis, B. Quesnel, S. Rigaudeau, C. Cordonnier, D. Bordessoule, H. Tilly, S. Corm, M. Michallet, J.M. Miclea, X. Thomas, S. Chevret, P. Fenaux, S. Castaigne
Journal: Blood
Blood (2007) 110 (11): 1857.
https://doi.org/10.1182/blood.V110.11.1857.1857
Published: 2007
Journal Articles

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Georges Fillet, C. Bonnet, N. Mounier, G. Ganem, T. Molina, C. Thieblemont, C. Fermé, B. Quesnel, C. Martin, C. Gisselbrecht, H. Tilly, F. Reyes
Journal: Blood
Blood (2005) 106 (11): 15.
https://doi.org/10.1182/blood.V106.11.15.15
Published: 2005
Journal Articles

p16 gene homozygous deletions in acute lymphoblastic leukemia

B Quesnel, C Preudhomme, N Philippe, M Vanrumbeke, I Dervite, JL Lai, F Bauters, E Wattel, P Fenaux
Journal: Blood
Blood (1995) 85 (3): 657–663.
https://doi.org/10.1182/blood.V85.3.657.bloodjournal853657
Published: 1995
Journal Articles

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

E Wattel, C Preudhomme, B Hecquet, M Vanrumbeke, B Quesnel, I Dervite, P Morel, P Fenaux
Journal: Blood
Blood (1994) 84 (9): 3148–3157.
https://doi.org/10.1182/blood.V84.9.3148.3148
Published: 1994